

New NAC members dedicated to solving the ‘puzzles’ of PI

Primary immunodeficiency can bring other immune system diagnoses

Volunteer established PI education groups 33 years ago

Ask the expert: PI and travel

Mavorixafor approved for treating WHIM syndrome

Insurers block immunoglobulin access using multiple tactics
Xolremdi
Mavorixafor.
Approved to treat: Warts, hypogammaglobulinemia, immunodeficiency, myelokathexis (WHIM) syndrome.
Ages: 12+
Report side effects/adverse events at 1-866-MED-X4MI (1-866-633-9464).

Family advocates for son with NEMO

Autoimmune diagnoses may obscure primary immunodeficiency
